相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The histone demethylase PHF8 regulates TGFβ signaling and promotes melanoma metastasis
Rana S. Moubarak et al.
SCIENCE ADVANCES (2022)
Histone demethylase PHF8 drives neuroendocrine prostate cancer progression by epigenetically upregulating FOXA2
Qiuli Liu et al.
JOURNAL OF PATHOLOGY (2021)
WLS-Wnt signaling promotes neuroendocrine prostate cancer
Tyler Bland et al.
ISCIENCE (2021)
Lgr4 Regulates Oviductal Epithelial Secretion Through the WNT Signaling Pathway
Xue Tan et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
TROP2 modulates the progression in papillary thyroid carcinoma
Huali Sun et al.
JOURNAL OF CANCER (2021)
SOX2 has dual functions as a regulator in the progression of neuroendocrine prostate cancer
Haiying Li et al.
LABORATORY INVESTIGATION (2020)
Trop2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1
En-Chi Hsu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
ERK/MAPK signalling pathway and tumorigenesis
Yan-Jun Guo et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2020)
MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer (vol 11, 338, 2020)
Yota Yasumizu et al.
NATURE COMMUNICATIONS (2020)
What turns CREB on? And off? And why does it matter?
Andre Steven et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
LIN28B promotes neuroblastoma metastasis and regulates PDZ binding kinase
Dongdong Chen et al.
NEOPLASIA (2020)
MUC1-C drives stemness in progression of colitis to colorectal cancer
Wei Li et al.
JCI INSIGHT (2020)
EZH2: a novel target for cancer treatment
Ran Duan et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
EGFR-upregulated LIFR promotes SUCLG2-dependent castration resistance and neuroendocrine differentiation of prostate cancer
Shian-Ren Lin et al.
ONCOGENE (2020)
Complex roles of cAMP-PKA-CREB signaling in cancer
Hongying Zhang et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2020)
Enzalutamide, an oral androgen receptor inhibitor for treatment of castration-resistant prostate cancer
Cora N. Sternberg
FUTURE ONCOLOGY (2019)
Inhibition of PTGS1 promotes osteogenic differentiation of adipose-derived stem cells by suppressing NF-kB signaling
Yuejun Wang et al.
STEM CELL RESEARCH & THERAPY (2019)
LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2/STAT3 signaling
Jie Luo et al.
NATURE COMMUNICATIONS (2019)
The MYC Oncogene Cooperates with Sterol-Regulated Element-Binding Protein to Regulate Lipogenesis Essential for Neoplastic Growth
Arvin M. Gouw et al.
CELL METABOLISM (2019)
Clinical features of neuroendocrine prostate cancer
Vincenza Conteduca et al.
EUROPEAN JOURNAL OF CANCER (2019)
Wnt activator FOXB2 drives the neuroendocrine differentiation of prostate cancer
Lavanya Moparthi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Androgen deprivation-induced ZBTB46-PTGS1 signaling promotes neuroendocrine differentiation of prostate cancer
Wei-Yu Chen et al.
CANCER LETTERS (2019)
ONECUT2 is a driver of neuroendocrine prostate cancer
Haiyang Guo et al.
NATURE COMMUNICATIONS (2019)
ONECUT2 overexpression promotes RAS-driven lung adenocarcinoma progression
Qingyang Ma et al.
SCIENTIFIC REPORTS (2019)
Androgen deprivation therapy-induced epithelial-mesenchymal transition of prostate cancer through downregulating SPDEF and activating CCL2
Yuan-Chin Tsai et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
Blockade of ONECUT2 expression in ovarian cancer inhibited tumor cell proliferation, migration, invasion and angiogenesis
Tongyi Lu et al.
CANCER SCIENCE (2018)
Phf8 histone demethylase deficiency causes cognitive impairments through the mTOR pathway
Xuemei Chen et al.
NATURE COMMUNICATIONS (2018)
ALK-rearrangement in non-small-cell lung cancer (NSCLC)
Xue Du et al.
THORACIC CANCER (2018)
Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers
Yan Zhang et al.
NATURE COMMUNICATIONS (2018)
ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis
Mirja Rotinen et al.
NATURE MEDICINE (2018)
RNA-binding protein LIN28B inhibits apoptosis through regulation of the AKT2/FOXO3A/BIM axis in ovarian cancer cells
Xiaojuan Lin et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2018)
FOXA2 is a sensitive and specific marker for small cell neuroendocrine carcinoma of the prostate
Jung Wook Park et al.
MODERN PATHOLOGY (2017)
IL-8 promotes proliferation and inhibition of apoptosis via STAT3/AKT/NF-κB pathway in prostate cancer
Yidi Guo et al.
MOLECULAR MEDICINE REPORTS (2017)
The multifaceted roles of PARP1 in DNA repair and chromatin remodelling
Arnab Ray Chaudhuri et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
FOXA1 inhibits prostate cancer neuroendocrine differentiation
J. Kim et al.
ONCOGENE (2017)
Inhibition of the androgen receptor induces a novel tumor promoter, ZBTB46, for prostate cancer metastasis
W-Y Chen et al.
ONCOGENE (2017)
Hyperactive mTOR induces neuroendocrine differentiation in prostate cancer cell with concurrent up-regulation of IRF1
Mayuko Kanayama et al.
PROSTATE (2017)
The HSF1-PARP13-PARP1 complex facilitates DNA repair and promotes mammary tumorigenesis
Mitsuaki Fujimoto et al.
NATURE COMMUNICATIONS (2017)
Overexpression of MUC1 and Genomic Alterations in Its Network Associate with Prostate Cancer Progression
Xiaozeng Lin et al.
NEOPLASIA (2017)
MUC1-C Oncoprotein Integrates a Program of EMT, Epigenetic Reprogramming and Immune Evasion in Human Carcinomas
Hasan Rajabi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2017)
N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer
Etienne Dardenne et al.
CANCER CELL (2016)
The transcription factor SPDEF suppresses prostate tumor metastasis (vol 287, pg 29968, 2012)
Joshua J. Steffan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
The HIF/PHF8/AR axis promotes prostate cancer progression
D. Tong et al.
ONCOGENESIS (2016)
Molecular landscape of prostate cancer: Implications for current clinical trials
Galina Khemlina et al.
CANCER TREATMENT REVIEWS (2015)
Leukemia inhibitory factor (LIF)
Nicos A. Nicola et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2015)
The CREB coactivator CRTC2 controls hepatic lipid metabolism by regulating SREBP1
Jinbo Han et al.
NATURE (2015)
The histone demethylase PHF8 promotes prostate cancer cell growth by activating the oncomiR miR-125b
Qiang Ma et al.
ONCOTARGETS AND THERAPY (2015)
Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma
Jiangbo Zhang et al.
ONCOTARGET (2015)
The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer
Shusuke Akamatsu et al.
CELL REPORTS (2015)
Lin28b Is Sufficient to Drive Liver Cancer and Necessary for Its Maintenance in Murine Models
Liem H. Nguyen et al.
CANCER CELL (2014)
Increased SNAIL expression and low syndecan levels are associated with high Gleason grade in prostate cancer
Cristian E. Poblete et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Evolution of androgen receptor targeted therapy for advanced prostate cancer
Yien Ning Sophia Wong et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Small cell carcinoma of the prostate
Rosa Nadal et al.
NATURE REVIEWS UROLOGY (2014)
Prostate cancer research in China
Shan-Cheng Ren et al.
ASIAN JOURNAL OF ANDROLOGY (2013)
The Sox Family of Transcription Factors: Versatile Regulators of Stem and Progenitor Cell Fate
Abby Sarkar et al.
CELL STEM CELL (2013)
Oncogenic Features of PHF8 Histone Demethylase in Esophageal Squamous Cell Carcinoma
Xiujing Sun et al.
PLOS ONE (2013)
Concurrent AURKA and MYCN Gene Amplifications Are Harbingers of Lethal TreatmentRelated Neuroendocrine Prostate Cancer
Juan Miguel Mosquera et al.
NEOPLASIA (2013)
Regulation of neuroendocrine differentiation by AKT/hnRNPK/AR/β-catenin signaling in prostate cancer cells
Monica Ciarlo et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin
Z-T Tong et al.
ONCOGENE (2012)
Prognostic Significance of Neuroendocrine Differentiation in Prostate Adenocarcinoma
Levent Sagnak et al.
CLINICAL GENITOURINARY CANCER (2011)
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Walter L. Miller et al.
ENDOCRINE REVIEWS (2011)
Siah2-Dependent Concerted Activity of HIF and FoxA2 Regulates Formation of Neuroendocrine Phenotype and Neuroendocrine Prostate Tumors
Jianfei Qi et al.
CANCER CELL (2010)
Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cells
Pinar Uysal-Onganer et al.
MOLECULAR CANCER (2010)
PHF8 mediates histone H4 lysine 20 demethylation events involved in cell cycle progression
Wen Liu et al.
NATURE (2010)
Wnt signal transduction pathways
Yuko Komiya et al.
Organogenesis (2010)
Stabilization of N-Myc Is a Critical Function of Aurora A in Human Neuroblastoma
Tobias Otto et al.
CANCER CELL (2009)
TUT4 in Concert with Lin28 Suppresses MicroRNA Biogenesis through Pre-MicroRNA Uridylation
Inha Heo et al.
CELL (2009)
TROP2 expression as prognostic marker for gastric carcinoma
G. Muehlmann et al.
JOURNAL OF CLINICAL PATHOLOGY (2009)
Dissecting Specificity in the Janus Kinases: The Structures of JAK-Specific Inhibitors Complexed to the JAK1 and JAK2 Protein Tyrosine Kinase Domains
Neal K. Williams et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Patched1 deletion increases N-Myc protein stability as a mechanism of medulloblastoma initiation and progression
W. D. Thomas et al.
ONCOGENE (2009)
High expression of TROP2 correlates with poor prognosis in pancreatic cancer
D. Fong et al.
BRITISH JOURNAL OF CANCER (2008)
Genetic deletion or pharmacological inhibition of cyclooxygenase-1 attenuate lipopolysaccharide-induced inflammatory response and brain injury
Sang Ho Choi et al.
FASEB JOURNAL (2008)
Roles of the EZH2 histone methyltransferase in cancer epigenetics
Jeffrey A. Simon et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2008)
let-7 microRNAs in development, stem cells and cancer
Ingo Buessing et al.
TRENDS IN MOLECULAR MEDICINE (2008)
Snail is a repressor of RK1P transcription in metastatic prostate cancer cells
S. Beach et al.
ONCOGENE (2008)
TROP2: a novel prognostic marker in squamous cell carcinoma of the oral cavity
Dominic Fong et al.
MODERN PATHOLOGY (2008)
Protocadherin-PC promotes androgen-independent prostate cancer cell growth
Stephane Terry et al.
PROSTATE (2006)
Wntless, a conserved membrane protein dedicated to the secretion of Wnt proteins from signaling cells
Carla Bänziger et al.
CELL (2006)
Liver receptor homolog 1 contributes to intestinal tumor formation through effects on cell cycle and inflammation
K Schoonjans et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
A second canon:: Functions and mechanisms of β-catenin-independent wnt signaling
MT Veeman et al.
DEVELOPMENTAL CELL (2003)
The polycomb group protein EZH2 is involved in progression of prostate cancer
S Varambally et al.
NATURE (2002)
The human EZH2 gene:: genomic organisation and revised mapping in 7q35 within the critical region for malignant myeloid disorders
C Cardoso et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2000)
PDEF, a novel prostate epithelium-specific Ets transcription factor, interacts with the androgen receptor and activates prostate-specific antigen gene expression
P Oettgen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
